Objective To investigate multidrug-resistant mycobacterium tuberculosis in TB patients co-infected with HIV and HIV negative TB patients,and provide scientific basis for prevention and individualized treatment of TB patients co-infected with HIV. Methods Clinical and laboratory data were retrospectively analyzed in TB patients hospitalized in the Nanning 4th Hospital from January 2004 to December 2008. The patients were divided into 2 groups:HIV positive and HIV negative group,and the strain identifications and the result of drug susceptibility tests (INH,RFP,EMB,SM) were analyzed. Results A total of 149 strains of mycobacterium tuberculosis(MTB)(including 61 drug-resistant strains) were isolated from HIV positive patients. The rate of total drug resistance was 40.94%,and the rate of total multi-drug resistance(MDR) was 18. 79%. The rates of initial drug resistance and initial MDR were 40.30% and 18.66%,respectively. The rates of acquired drug resistance and acquired MDR were 46.67% and 20.0%,respectively. In the HIV negative group (2152 cases of positive MTB culture ),the rate of total MDR,initial MDR and acquired MDR were 15.94%,8.25% and 32.36%,respectively. These data indicated that the rate of initial MDR in the HIV positive group was significantly higher than in the HIV negative group (P0.01). Conclusions The tendency of multidrug-resistance of mycobacterium tuberculosis in TB patients co-infected with HIV has increased in the past 5 years. Multiple resistance to two or more antibiotics is frequent. Long-term monitoring of multidrug-resistance of MTB is important for guiding clinical treatment of TB patients co-infected with HIV.